Low Vitamin D Symptoms: Labs, Diagnosis, and Next Steps

How Common Is Vitamin D Deficiency?

Vitamin D deficiency is one of the most prevalent nutritional shortfalls worldwide. A NHANES analysis found that 41.6% of U.S. adults have 25(OH)D levels below 20 ng/mL, with rates climbing to 82.1% among non-Hispanic Black adults and 69.2% among Hispanic adults [1].

The problem is not limited to northern latitudes. Indoor lifestyles, sunscreen use, and obesity have driven deficiency rates higher across all climates over the past two decades. A 2020 meta-analysis published in The Lancet Diabetes & Endocrinology estimated that 1 billion people globally have vitamin D deficiency or insufficiency [2]. The Endocrine Society's 2024 clinical practice guideline identifies vitamin D deficiency as a public health concern requiring targeted screening in at-risk populations rather than universal testing [3].

People with BMI above 30 are particularly vulnerable. Adipose tissue sequesters the fat-soluble vitamin, reducing bioavailability. Bariatric surgery patients, those with celiac disease, Crohn's disease, or chronic kidney disease face compounding absorption challenges.

Recognizing the Symptoms

The symptoms of low vitamin D range from subtle fatigue to debilitating musculoskeletal pain, and they often overlap with other common conditions. That overlap is precisely why lab confirmation matters.

Musculoskeletal complaints dominate. Proximal muscle weakness (difficulty rising from a chair or climbing stairs without arm support) affects up to 60% of adults with levels below 12 ng/mL [4]. Diffuse bone pain, particularly in the lower back, pelvis, and shins, results from impaired calcium absorption and secondary hyperparathyroidism. A BMJ review noted that adults with severe deficiency may develop osteomalacia, characterized by bone tenderness on palpation and waddling gait [5].

Fatigue is the symptom patients report most frequently but attribute least often to vitamin D. A randomized controlled trial (N=120) published in Medicine found that vitamin D supplementation significantly reduced fatigue severity scores in deficient adults compared to placebo over 8 weeks [6].

Mood disturbances include low mood, irritability, and seasonal patterns. A 2014 meta-analysis of 31,424 participants in The British Journal of Psychiatry found that individuals with 25(OH)D below 20 ng/mL had a 31% higher odds of depression compared to those with sufficient levels (OR 1.31 to 95% CI 1.0 to 1.71) [7].

Other symptoms include:

• Impaired wound healing
• Hair thinning or telogen effluvium
• Recurrent respiratory infections
• Paresthesias in hands and feet (when calcium drops secondarily)

Not every person with deficiency experiences symptoms. Some are completely asymptomatic, discovered only through routine bloodwork.

What Causes Low Vitamin D?

Deficiency results from inadequate synthesis, poor intake, impaired absorption, or accelerated metabolism. Most cases involve more than one contributing factor operating simultaneously.

Reduced skin synthesis accounts for the majority of deficiency in industrialized populations. UVB radiation (wavelength 290 to 315 nm) converts 7-dehydrocholesterol in the skin to previtamin D3. Living above the 37th parallel north means insufficient UVB from November through March. Melanin acts as a natural sunscreen; individuals with Fitzpatrick skin types IV through VI require 3 to 5 times longer sun exposure to produce equivalent vitamin D compared to type I or II skin [8].

Dietary insufficiency compounds the problem. Few foods naturally contain meaningful amounts. Wild-caught salmon provides approximately 600 to 1 to 000 IU per 3.5 oz serving; fortified milk provides about 100 IU per cup. The average American dietary intake falls between 150 and 300 IU daily, well below the 600 to 800 IU recommended by the Institute of Medicine [9].

Malabsorption syndromes prevent intestinal uptake of ingested vitamin D. Celiac disease, inflammatory bowel disease, pancreatic insufficiency, and prior gastric bypass surgery all impair fat-soluble vitamin absorption. These patients may require 2 to 3 times standard dosing to achieve repletion.

Medications accelerate vitamin D catabolism. Phenytoin, carbamazepine, phenobarbital, rifampin, and certain antiretrovirals induce hepatic CYP enzymes that break down 25(OH)D and 1,25(OH)2D. Glucocorticoids reduce intestinal calcium absorption independently.

Obesity remains an underappreciated driver. A study of 12,000 participants in The Journal of Clinical Endocrinology & Metabolism found that each unit increase in BMI above 30 was associated with a 1.15% decrease in serum 25(OH)D [10].

The Right Lab Test: 25-Hydroxyvitamin D

Serum 25-hydroxyvitamin D (calcidiol) is the standard biomarker. It reflects both dietary intake and cutaneous synthesis, with a circulating half-life of approximately 2 to 3 weeks. Do not order 1,25-dihydroxyvitamin D (calcitriol) for screening; it is tightly regulated by parathyroid hormone and may appear normal or elevated even in severe deficiency.

The Endocrine Society defines the thresholds as follows [3]:

• Deficient: <20 ng/mL (<50 nmol/L)
• Insufficient: 20 to 29 ng/mL (50 to 72 nmol/L)
• Sufficient: 30 to 100 ng/mL (75 to 250 nmol/L)
• Potentially toxic: >100 ng/mL (>250 nmol/L)

The Institute of Medicine uses a slightly different threshold, placing sufficiency at 20 ng/mL, creating clinical debate [9]. For patients with musculoskeletal symptoms, most endocrinologists target 30 ng/mL or above.

Ancillary labs add context. When 25(OH)D is below 20 ng/mL, consider ordering:

• Intact PTH (elevated in secondary hyperparathyroidism)
• Serum calcium and phosphorus
• Alkaline phosphatase (elevated in osteomalacia)
• 24-hour urine calcium (before high-dose repletion in kidney stone formers)
• Magnesium (cofactor for vitamin D metabolism; deficiency blunts response to supplementation)

Dr. Michael Holick, professor of medicine at Boston University and author of the seminal 2007 NEJM review on vitamin D deficiency, stated: "A 25-hydroxyvitamin D level below 20 ng/mL should be treated aggressively, particularly in patients presenting with proximal muscle weakness or unexplained bone pain" [4].

Who Should Be Tested?

The Endocrine Society's 2024 guideline does not recommend universal screening. Targeted testing is indicated for [3]:

• Patients with unexplained musculoskeletal pain or weakness
• Osteoporosis or osteopenia on DEXA
• History of low-trauma fracture
• Malabsorption disorders (celiac, IBD, pancreatic insufficiency)
• Chronic kidney disease (stages 3 to 5)
• Obesity (BMI 30 or above)
• Medications that accelerate vitamin D catabolism
• Darker skin pigmentation with limited sun exposure
• Pregnancy and lactation
• Older adults in residential care facilities

The U.S. Preventive Services Task Force (USPSTF) concluded in its 2021 recommendation that evidence is insufficient to assess the balance of benefits and harms of screening for vitamin D deficiency in asymptomatic adults [11]. This does not mean testing is inappropriate in symptomatic patients. It means mass screening of healthy populations lacks proven benefit.

Treatment Protocols

Treatment depends on severity, underlying cause, and patient-specific factors. The goal is to restore serum 25(OH)D to at least 30 ng/mL and maintain it there.

Initial repletion for adults with levels below 20 ng/mL:

The Endocrine Society recommends ergocalciferol (D2) or cholecalciferol (D3) 50 to 000 IU once weekly for 8 weeks [3]. A head-to-head trial in The Journal of Clinical Endocrinology & Metabolism (N=68) demonstrated that D3 was approximately 87% more effective than D2 at raising and maintaining serum 25(OH)D over 12 weeks [12]. Many clinicians now prefer D3 for this reason.

Maintenance dosing after repletion:

• General adults: 1,000 to 2 to 000 IU cholecalciferol daily
• Obese adults (BMI 30+): 3,000 to 6 to 000 IU daily
• Malabsorptive conditions: 3,000 to 6 to 000 IU daily, or 50 to 000 IU once or twice weekly
• Post-bariatric surgery: up to 50 to 000 IU two to three times weekly if oral absorption fails

Monitoring: Recheck 25(OH)D levels 3 months after initiating therapy. Avoid retesting earlier; the half-life of 25(OH)D means levels take 6 to 8 weeks to reach a new steady state.

A 2019 Cochrane review of 81 RCTs (N=53,537) found that vitamin D supplementation modestly reduced all-cause mortality (RR 0.97 to 95% CI 0.94 to 0.99) when given as D3 rather than D2, with the strongest benefit observed in deficient elderly populations [13].

The VITAL trial (N=25,871), published in The New England Journal of Medicine, found that 2 to 000 IU daily vitamin D3 supplementation in a general population (mean baseline 25(OH)D of 30.8 ng/mL) did not reduce cancer or cardiovascular events over 5.3 years [14]. This trial enrolled vitamin D-sufficient participants; its results do not apply to the treatment of confirmed deficiency.

When Symptoms Do Not Improve

If symptoms persist after documented normalization of 25(OH)D, re-evaluate the differential. Fatigue, pain, and mood changes have broad etiologies.

Consider:

• Hypothyroidism (check TSH, free T4)
• Iron deficiency with or without anemia (ferritin, TIBC)
• B12 deficiency (methylmalonic acid if borderline serum B12)
• Primary hyperparathyroidism (calcium elevated with inappropriately normal or elevated PTH)
• Depression meeting DSM-5 criteria independent of vitamin status
• Fibromyalgia or central sensitization syndromes
• Sleep disorders (obstructive sleep apnea, insufficient sleep)

Dr. JoAnn Manson, professor of medicine at Harvard Medical School and principal investigator of the VITAL trial, noted: "Vitamin D is not a panacea. Correcting a deficiency should be part of a comprehensive clinical evaluation, not the end of one" [14].

Special Populations

Pregnant women: The American College of Obstetricians and Gynecologists (ACOG) recommends 600 IU daily as minimum intake during pregnancy [15]. A 2017 RCT (N=346) found that 4 to 000 IU daily was safe and more effective at achieving sufficiency (defined as 32 ng/mL or above) in pregnant women compared to 400 IU, with no adverse effects on maternal or neonatal outcomes [16].

Chronic kidney disease: As GFR declines, renal 1-alpha-hydroxylase activity drops, reducing conversion of 25(OH)D to active 1,25(OH)2D. KDIGO guidelines recommend correcting 25(OH)D deficiency first, then considering calcitriol or active vitamin D analogs (paricalcitol, doxercalciferol) for patients with CKD stages 3 to 5 and elevated PTH [17].

Elderly adults in long-term care: A meta-analysis in BMJ found that daily vitamin D supplementation (700 to 1 to 000 IU) reduced fall risk by 19% in community-dwelling older adults with deficiency (RR 0.81 to 95% CI 0.71 to 0.92) [18]. The benefit was absent with intermittent high-dose boluses (e.g., 500 to 000 IU annually), which paradoxically increased fall risk in one Australian trial [19].

Lifestyle Measures That Support Repletion

Supplementation works best alongside targeted lifestyle modifications. Neither approach alone is sufficient for patients with severe deficiency.

Sun exposure: Ten to 30 minutes of midday sun on forearms and legs, without sunscreen, 2 to 3 times per week produces approximately 10,000 to 20 to 000 IU in fair-skinned individuals [4]. This is not feasible year-round in northern latitudes, and skin cancer risk must be balanced against vitamin D synthesis.

Dietary sources with meaningful content:

• Wild salmon (3.5 oz): 600 to 1 to 000 IU
• Canned sardines (3.5 oz): 300 IU
• Egg yolk (1 large): 40 IU
• Fortified milk (8 oz): 100 IU
• Cod liver oil (1 tsp): 400 to 1 to 000 IU
• UV-exposed mushrooms (3.5 oz): 400 IU (D2)

Magnesium co-supplementation: Magnesium is required for vitamin D metabolism at multiple enzymatic steps. A clinical trial (N=180) in The American Journal of Clinical Nutrition found that magnesium supplementation (400 mg daily) optimized 25(OH)D status, raising levels in deficient participants and preventing excess in those already sufficient [20].

Weight management: Each 10% reduction in body weight in obese individuals correlates with a 3 to 5 ng/mL increase in serum 25(OH)D, independent of supplementation changes [10].

Red Flags Requiring Urgent Evaluation

Most vitamin D deficiency is managed outpatient with oral supplementation. Certain presentations require prompt workup:

• Serum calcium above 11.0 mg/dL with elevated PTH (possible primary hyperparathyroidism, not just secondary)
• Pathologic fracture with minimal trauma
• Tetany or carpopedal spasm (severe hypocalcemia secondary to vitamin D deficiency)
• Failure to respond to adequate supplementation (consider non-compliance, malabsorption, or rare genetic disorders like vitamin D-dependent rickets)
• Pediatric rickets (bowing deformities, craniotabes, rachitic rosary)

For confirmed deficiency in an otherwise stable adult: start ergocalciferol or cholecalciferol 50 to 000 IU weekly for 8 weeks, add magnesium 400 mg daily, recheck 25(OH)D and PTH at 12 weeks, and transition to maintenance dosing of 2 to 000 IU cholecalciferol daily once levels reach 30 ng/mL or above [3].